Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients

被引：14

作者：

de las Heras, Begona ^{[1
,2
]}

Daehnke, Adam ^{[1
]}

Saini, Kamal S. ^{[1
]}

Harris, Melissa ^{[1
]}

Morrison, Kenneth ^{[1
]}

Aguilo, Ariel ^{[1
]}

Chico, Isagani ^{[1
]}

Vidal, Laura ^{[1
]}

Marcus, Robin ^{[1
]}

机构：

[1] Labcorp Drug Dev Inc, Burlington, NC 27215 USA

[2] Madrid Med Doctors Assoc, Madrid, Spain

来源：

DIGITAL HEALTH | 2022年 / 8卷

关键词：

Decentralized clinical trials; hybrid; virtual; remote clinical trial; patient centricity; oncology; COVID-19; pandemic; tele-oncology; cancer; survey; PARTICIPATION; COVID-19; CALL; ERA; AGE;

D O I：

10.1177/20552076221099997

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

As a result of the unprecedented challenges imposed by the COVID-19 pandemic on enrollment to cancer clinical trials, there has been an urgency to identify and incorporate new solutions to mitigate these difficulties. The concept of decentralized or hybrid clinical trials has rapidly gained currency, given that it aims to reduce patient burden, increase patient enrollment and retention, and preserve quality of life, while also increasing the efficiency of trial logistics. Therefore, the clinical trial environment is moving toward remote collection and assessment of data, transitioning from the classic site-centric model to one that is more patient-centric.

引用

页数：24

共 47 条

[1] Virtual Clinical Trials: Perspectives in Dermatology [J].

Ali, Zarqa ;

Zibert, John Robert ;

Thomsen, Simon Francis .

DERMATOLOGY, 2020, 236 (04) :375-382

[2]

[Anonymous], 2020, SOL CLIN TRIAL COVID

[3] Uveitis Specialists Harnessing Disruptive Technology during the COVID-19 Pandemic and Beyond [J].

Brill, Daniel ;

Papaliodis, George .

SEMINARS IN OPHTHALMOLOGY, 2021, 36 (04) :296-303

[4]

Center for Information and Study on Clinical Research Participation (CISCRP), 2017, PERC INS STUD GEN PE

[5]

Center for Information & Study on Research Participation (CISCRP), 2019, PERC INS STUD GEN PE

[6]

Collyar D, 2017, CLIN ADV HEMATOL ONC, V15, P262

[7] Use of Wearable, Mobile, and Sensor Technology in Cancer Clinical Trials [J].

Cox, Suzanne M. ;

Lane, Ashley ;

Volchenboum, Samuel L. L. .

JCO CLINICAL CANCER INFORMATICS, 2018, 2 :1-11

[8] Remote Methods for Conducting Tobacco-Focused Clinical Trials [J].

Dahne, Jennifer ;

Tomko, Rachel L. ;

McClure, Erin A. ;

Obeid, Jihad S. ;

Carpenter, Matthew J. .

NICOTINE & TOBACCO RESEARCH, 2020, 22 (12) :2134-2140

[9] Results from a global survey of clinical cancer researchers on clinical trial design and conduct during the COVID-19 pandemic and beyond. [J].

De Paula, Bruno Henrique Rala ;

Doherty, Gary .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

[10]

Desai Aakash, 2021, J Immunother Precis Oncol, V4, P64, DOI 10.36401/JIPO-20-X7

← 1 2 3 4 5 →